Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M – MedCity News
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
閱讀中文版 / Leer en español Michael Lai, a frontrunner in the District 11 supervisorial race, tells voters that he’s an…